Dr. Krzysztof W. Pankiewicz of the Center for Drug Design has received a grant from the Department of Defense, funding his research on treatment of chronic myelogenous leukemia by developing inhibitors specific for Type II IMP Dehydrogenase (IMPDH).
Start Date